Thermo Fisher Scientific ROA 2010-2024 | TMO
Current and historical return on assets (ROA) values for Thermo Fisher Scientific (TMO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Thermo Fisher Scientific ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $6.14B | $100.36B | 6.22% |
| 2024-06-30 | $6.22B | $98.50B | 6.36% |
| 2024-03-31 | $6.03B | $97.10B | 6.24% |
| 2023-12-31 | $6.00B | $98.73B | 6.24% |
| 2023-09-30 | $5.94B | $97.06B | 6.21% |
| 2023-06-30 | $5.72B | $94.11B | 6.08% |
| 2023-03-31 | $6.02B | $94.66B | 6.46% |
| 2022-12-31 | $6.95B | $97.15B | 7.49% |
| 2022-09-30 | $7.03B | $90.54B | 7.62% |
| 2022-06-30 | $7.44B | $90.58B | 8.45% |
| 2022-03-31 | $7.60B | $92.75B | 9.24% |
| 2021-12-31 | $7.73B | $95.12B | 10.22% |
| 2021-09-30 | $8.57B | $73.60B | 12.40% |
| 2021-06-30 | $8.60B | $67.70B | 12.89% |
| 2021-03-31 | $7.92B | $65.93B | 12.16% |
| 2020-12-31 | $6.38B | $69.05B | 10.06% |
| 2020-09-30 | $4.88B | $64.06B | 8.04% |
| 2020-06-30 | $3.71B | $61.59B | 6.30% |
| 2020-03-31 | $3.67B | $58.69B | 6.33% |
| 2019-12-31 | $3.70B | $58.38B | 6.47% |
| 2019-09-30 | $3.59B | $56.73B | 6.34% |
| 2019-06-30 | $3.54B | $57.97B | 6.30% |
| 2019-03-31 | $3.17B | $55.60B | 5.71% |
| 2018-12-31 | $2.94B | $56.23B | 5.26% |
| 2018-09-30 | $2.57B | $55.08B | 4.59% |
| 2018-06-30 | $2.39B | $55.40B | 4.26% |
| 2018-03-31 | $2.25B | $56.58B | 4.18% |
| 2017-12-31 | $2.23B | $56.67B | 4.33% |
| 2017-09-30 | $2.33B | $55.99B | 4.78% |
| 2017-06-30 | $2.27B | $46.51B | 4.86% |
| 2017-03-31 | $2.17B | $46.21B | 4.76% |
| 2016-12-31 | $2.02B | $45.91B | 4.52% |
| 2016-09-30 | $2.00B | $48.01B | 4.58% |
| 2016-06-30 | $2.00B | $42.25B | 4.78% |
| 2016-03-31 | $1.99B | $42.95B | 4.78% |
| 2015-12-31 | $1.98B | $40.83B | 4.77% |
| 2015-09-30 | $1.97B | $41.15B | 4.71% |
| 2015-06-30 | $1.97B | $41.77B | 4.66% |
| 2015-03-31 | $1.74B | $41.86B | 4.05% |
| 2014-12-31 | $1.90B | $42.85B | 4.31% |
| 2014-09-30 | $1.64B | $42.69B | 3.97% |
| 2014-06-30 | $1.48B | $44.31B | 3.94% |
| 2014-03-31 | $1.48B | $46.13B | 4.42% |
| 2013-12-31 | $1.27B | $31.86B | 4.42% |
| 2013-09-30 | $1.31B | $28.27B | 4.72% |
| 2013-06-30 | $1.28B | $27.63B | 4.65% |
| 2013-03-31 | $1.24B | $27.41B | 4.54% |
| 2012-12-31 | $1.18B | $27.45B | 4.35% |
| 2012-09-30 | $1.09B | $27.58B | 4.05% |
| 2012-06-30 | $1.07B | $26.36B | 3.98% |
| 2012-03-31 | $1.35B | $26.82B | 5.17% |
| 2011-12-31 | $1.33B | $26.83B | 5.25% |
| 2011-09-30 | $1.34B | $26.99B | 5.58% |
| 2011-06-30 | $1.34B | $24.07B | 5.93% |
| 2011-03-31 | $1.06B | $23.43B | 4.82% |
| 2010-12-31 | $1.04B | $21.35B | 4.83% |
| 2010-09-30 | $1.01B | $21.54B | 4.70% |
| 2010-06-30 | $0.96B | $21.28B | 4.48% |
| 2010-03-31 | $0.93B | $21.63B | 4.35% |
| 2009-12-31 | $0.85B | $21.63B | 3.99% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $207.434B | $42.857B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.997B | 101.95 |
| Edwards Lifesciences (EW) | United States | $43.303B | 27.50 |
| Alcon (ALC) | Switzerland | $41.141B | 27.53 |
| IQVIA Holdings (IQV) | United States | $36.894B | 20.33 |
| IDEXX Laboratories (IDXX) | United States | $34.232B | 40.31 |
| DexCom (DXCM) | United States | $30.373B | 45.74 |
| Waters (WAT) | United States | $22.584B | 33.39 |
| STERIS (STE) | Ireland | $20.308B | 23.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.662B | 0.00 |
| Hologic (HOLX) | United States | $16.272B | 17.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.198B | 13.55 |
| Globus Medical (GMED) | United States | $11.856B | 30.02 |
| Sysmex ADR (SSMXY) | Japan | $11.516B | 36.11 |
| Penumbra (PEN) | United States | $9.619B | 94.22 |
| Masimo (MASI) | United States | $8.910B | 43.11 |
| Glaukos (GKOS) | United States | $8.631B | 0.00 |
| Teleflex (TFX) | United States | $8.110B | 12.93 |
| Inari Medical (NARI) | United States | $4.642B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.532B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.486B | 25.42 |
| Veracyte (VCYT) | United States | $3.219B | 96.60 |
| LivaNova (LIVN) | United Kingdom | $2.534B | 14.63 |
| Nihon Kohden (NHNKY) | Japan | $2.370B | 18.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.364B | 0.00 |
| TransMedics (TMDX) | United States | $2.309B | 73.20 |
| Elekta AB (EKTAY) | Sweden | $2.138B | 19.22 |
| Integra LifeSciences Holdings (IART) | United States | $1.683B | 8.79 |
| Alphatec Holdings (ATEC) | United States | $1.414B | 0.00 |
| RxSight (RXST) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.253B | 83.00 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AxoGen (AXGN) | United States | $0.794B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.730B | 17.21 |
| IRadimed (IRMD) | United States | $0.717B | 38.76 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.699B | 11.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.650B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| SiBone (SIBN) | United States | $0.575B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.498B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.476B | 25.05 |
| Treace Medical Concepts (TMCI) | United States | $0.455B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.413B | 22.38 |
| ClearPoint Neuro (CLPT) | United States | $0.405B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| CVRx (CVRX) | United States | $0.344B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Nevro (NVRO) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 11.47 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.057B | 0.00 |
| Neuronetics (STIM) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |